✦ LIBER ✦

Comparison of adjuvant therapy with tamoxifen and goserelin vs. CMF in premenopausal stage I and II hormone-responsive breast cancer patients: four-year results of Austrian Breast Cancer Study Group (ABCSG) trial 5

✍ Scribed by R. Jakesz; H. Hausmaninger; H. Samonigg; E. Kubista; D. Depisch; M. Fridrik; M. Stierer; M. Gnant; G. Steger; R. Kolb; G. Jatzko; F. Hofbauer; G. Reiner; P. Steindorfer

Book ID: 117667251
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 118 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)80701-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of adjuvant endocrine treatme

Comparison of adjuvant endocrine treatment (tamoxifen and goserelin) vs. chemotherapy (CMF) in premenopausal patients with hormone-responsive early breast cancer: Results from the Austrian Breast Cancer Study Group (ABCSG)

✍ E. Kubista; M. Seifert; M. Gnant; R. Jakesz 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Postoperative adjuvant randomised trial

Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of Japan

✍ T. Morimoto; M. Ogawa; K. Orita; K. Sugimachi; T. Toge; K. Dohi; Y. Nomura; Y. M 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 899 KB

Randomized adjuvant trial to evaluate th

Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization

✍ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

396 Randomized controlled study comparin

396 Randomized controlled study comparing surgery alone, surgery plus tamoxifen, and surgery plus tegafur-uracil in patients with node-negative breast cancer: 5-year results from the Kanto cooperative study group of adjuvant chemo-endocrine therapy for breast cancer (ACETBC) of Japan

✍ M. Kusama; T. Ikeda; K. Enomoto; F. Kasumi; T. Tominaga; S. Haga; M. Fukuda; S. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views